#### /order-select/digoxin-cyclosporine-cds-select

ジゴキシン (ジゴキシン 0.2 MG 経口カプセル) とシクロスポリン (シクロスポリン 100 MG) の間の潜在的な薬物相互作用

##### [API共通仕様](./api_000.md)

メソッド
> POST

コンテキストパス
> {baseUrl} /order-select/digoxin-cyclosporine-cds-select

リクエストサンプル
```bash
curl --location 'http://example.com/order-select/digoxin-cyclosporine-cds-select' \
--header 'Content-Type: text/plain' \
--data '{
  "hookInstance": "9d02e4d7-2d5b-492f-8f77-ce36dda0647d",
  "fhirServer": "http://46.101.183.140:8080/baseDstu3",
  "hook": "order-select",
  "user": "Practitioner/example",
  "applyCql": "true",
  "context": {
    "patientId": "Patient/patient-warfarin-nsaid-over65-prefetch",
    "encounterId": "Encounter/encounter-warfarin-nsaid-context",
    "medications": {
      "resourceType": "Bundle",
      "entry": [
        {
          "resourceType": "MedicationRequest",
          "id": "medicationrequest-warfarin-nsaid-topicaldiclofenac-context",
          "status": "active",
          "intent": "order",
          "category": [
            {
              "coding": [
                {
                  "code": "outpatient"
                }
              ]
            }
          ],
          "medicationCodeableConcept": {
            "coding": [
              {
                "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
                "code": "855635",
                "display": "Diclofenac Sodium 0.01 MG/MG Topical Gel [Voltaren]"
              }
            ]
          },
          "subject": {
            "reference": "Patient/warfarin-nsaid-over65-prefetch"
          },
          "context": {
            "reference": "Encounter/warfarin-nsaid-prefetch"
          },
          "_authoredOn": {
            "extension": [
              {
                "url": "http://hl7.org/fhir/StructureDefinition/cqif-cqlExpression",
                "valueString": "Today()"
              }
            ]
          },
          "dosageInstruction": [
            {
              "timing": {
                "repeat": {
                  "frequency": 1,
                  "period": 1.0,
                  "periodUnit": "d"
                }
              },
              "asNeededBoolean": false
            }
          ],
          "dispenseRequest": {
            "validityPeriod": {
              "extension": [
                {
                  "url": "http://hl7.org/fhir/StructureDefinition/cqif-cqlExpression",
                  "valueString": "FHIR.Period { start: FHIR.dateTime { value: Today() }, end: FHIR.dateTime { value: Today() } }"
                }
              ]
            },
            "numberOfRepeatsAllowed": 1,
            "expectedSupplyDuration": {
              "value": 90.0,
              "unit": "d"
            }
          }
        }
      ]
    },
    "prefetch": {
      "item1": {
        "response": {
          "status": "200 OK"
        },
        "resource": {
          "resourceType": "Bundle",
          "entry": [
            {
              "resourceType" : "MedicationRequest",
              "id" : "medicationrequest-warfarin-nsaid-warfarin-prefetch",
              "status" : "active",
              "intent" : "order",
              "category" : [
                {
                  "coding" : [
                    {
                      "code" : "outpatient"
                    }
                  ]
                }
              ],
              "medicationCodeableConcept" : {
                "coding" : [
                  {
                    "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
                    "code" : "855295",
                    "display" : "Warfarin Sodium 10 MG"
                  }
                ]
              },
              "subject" : {
                "reference" : "Patient/warfarin-nsaid-over65-prefetch"
              },
              "context" : {
                "reference" : "Encounter/warfarin-nsaid-prefetch"
              },
              "_authoredOn" : {
                "extension" : [
                  {
                    "url" : "http://hl7.org/fhir/StructureDefinition/cqif-cqlExpression",
                    "valueString" : "Today() - 90 days"
                  }
                ]
              },
              "dosageInstruction" : [
                {
                  "timing" : {
                    "repeat" : {
                      "frequency" : 1,
                      "period" : 1.0,
                      "periodUnit" : "d"
                    }
                  },
                  "asNeededBoolean" : false
                }
              ],
              "dispenseRequest" : {
                "validityPeriod" : {
                  "extension" : [
                    {
                      "url" : "http://hl7.org/fhir/StructureDefinition/cqif-cqlExpression",
                      "valueString" : "FHIR.Period { start: FHIR.dateTime { value: Today() - 90 days }, end: FHIR.dateTime { value: Today() } }"
                    }
                  ]
                },
                "numberOfRepeatsAllowed" : 1,
                "expectedSupplyDuration" : {
                  "value" : 90,
                  "unit" : "d"
                }
              }
            }
          ]
        }
      }
    }
  }
}'
```
レスポンスサンプル
```bash
{
    "cards": [
        {
            "uuid": "8d86629d-79d3-4502-83fa-776eb54ea8fc",
            "summary": "ジゴキシン (ジゴキシン 0.2 MG 経口カプセル) とシクロスポリン (シクロスポリン 100 MG) の間の潜在的な薬物相互作用",
            "indicator": "warning",
            "detail": "ジゴキシン毒性のリスクが増加します。 リスクを評価し、必要に応じて措置を講じます。 \nジゴキシンの毒性は深刻な可能性があります。 臨床結果には、食欲不振、吐き気、嘔吐、視覚的変化、不整脈などが含まれる場合があります。 \nこの相互作用のメカニズムは、シクロスポリンによる P 糖タンパク質の阻害を介して媒介されるようです。 P-糖タンパク質は、ジゴキシン流出の主要な輸送体です。",
            "source": {
                "label": "潜在的な薬物間相互作用の臨床意思決定のサポート",
                "url": "http://hl7.org/fhir/ig/PDDI-CDS"
            },
            "suggestions": [
                {
                    "label": "Consultation",
                    "actions": [
                        {
                            "type": "create",
                            "description": "ジゴキシン処方者とのコミュニケーションをリクエストする",
                            "resource": {
                                "resourceType": "ProcedureRequest",
                                "id": "70ef559c-a02d-463d-8505-9beb9c2629c3",
                                "status": "draft",
                                "intent": "order",
                                "code": {
                                    "coding": [
                                        {
                                            "system": "http://snomed.info/sct",
                                            "code": "11429006",
                                            "display": "Consultation"
                                        }
                                    ],
                                    "text": "Consultation"
                                },
                                "subject": {
                                    "reference": "f001"
                                }
                            }
                        }
                    ]
                },
                {
                    "label": "Cancel digoxin",
                    "actions": [
                        {
                            "type": "delete",
                            "description": "Discontinue digoxin order"
                        }
                    ]
                }
            ]
        },
        {
            "summary": "患者には過去 30 日以内に記録上のジゴキシンレベルがありません。",
            "indicator": "warning",
            "detail": "シクロスポリンの投与を開始すると、ジゴキシンレベルが上昇すると予想されます。 信頼できる血漿ジゴキシン濃度が正常範囲にない患者の場合は、リスクを上回る利益がある場合にのみ使用してください。 細心の注意と厳重な監視が必要です。",
            "source": {
                "label": "潜在的な薬物間相互作用の臨床意思決定のサポート",
                "url": "http://hl7.org/fhir/ig/PDDI-CDS"
            },
            "suggestions": [
                {
                    "label": "Digoxin Level",
                    "actions": [
                        {
                            "type": "create",
                            "description": "シクロスポリンの投与開始から 24 時間以内にジゴキシントラフを注文する",
                            "resource": {
                                "resourceType": "ProcedureRequest",
                                "id": "79d64211-25f6-4e8c-babe-856816127d1b",
                                "status": "draft",
                                "intent": "order",
                                "code": {
                                    "coding": [
                                        {
                                            "system": "http://snomed.info/sct",
                                            "code": "269872007",
                                            "display": "血清ジゴキシン測定"
                                        }
                                    ],
                                    "text": "血清ジゴキシン測定"
                                },
                                "subject": {
                                    "reference": "f001"
                                }
                            }
                        }
                    ]
                },
                {
                    "label": "New Digoxin",
                    "actions": [
                        {
                            "type": "create",
                            "description": "新しいオーダーでジゴキシンの用量を先制的に減らす ",
                            "resource": {
                                "resourceType": "MedicationRequest",
                                "id": "3c428362-5646-4131-9f96-937a7df5dbf4",
                                "intent": "order",
                                "medicationCodeableConcept": {
                                    "coding": [
                                        {
                                            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
                                            "code": "315819",
                                            "display": "Digoxin 0.125 MG"
                                        }
                                    ],
                                    "text": "Digoxin 0.125 MG"
                                },
                                "subject": {
                                    "reference": "f001"
                                }
                            }
                        }
                    ]
                }
            ],
            "links": [
                {
                    "label": "ジゴキシン-シクロスポリン PDDI 知識成果物",
                    "url": "http://hl7.org/fhir/ig/PDDI-CDS/derived-from#digoxin-cyclosporine-knowledge-artifact"
                },
                {
                    "label": "(Dorian et al. Clin Invest Med 1988; 11(2):108-112) ",
                    "url": "http://hl7.org/fhir/ig/PDDI-CDS/citation#dorian1988"
                },
                {
                    "label": "(Dorian et al. Transplant Proc. 1987; 19(1):1825-1827)",
                    "url": "http://hl7.org/fhir/ig/PDDI-CDS/citation#dorian#1987"
                }
            ]
        },
        {
            "summary": "100 日以内に患者は電解質と血清クレアチニンのレベルを検査されており、カリウム節約薬やループ利尿薬を服用していません。",
            "indicator": "info",
            "detail": "(カリウム: 3.6mEq/L および 2020-04-28)\n (マグネシウム: 0.8mmol/L および 2020-04-28)\n (カルシウム: 8.6mg/dL および 2020-04-28)\n",
            "source": {
                "label": "潜在的な薬物間相互作用の臨床意思決定のサポート",
                "url": "http://hl7.org/fhir/ig/PDDI-CDS"
            },
            "suggestions": [
                {
                    "label": "セラム・クレアチン",
                    "actions": [
                        {
                            "type": "create",
                            "description": "血清クレアチニンの注文",
                            "resource": {
                                "resourceType": "ProcedureRequest",
                                "id": "85d53af2-22ec-4441-8ecf-f71879779f2a",
                                "status": "draft",
                                "intent": "order",
                                "code": {
                                    "coding": [
                                        {
                                            "system": "http://snomed.info/sct",
                                            "code": " 313822004",
                                            "display": "補正された血清クレアチニン"
                                        }
                                    ],
                                    "text": "セラム・クレアチン"
                                },
                                "subject": {
                                    "reference": "f001"
                                }
                            }
                        }
                    ]
                },
                {
                    "label": "電解質パネル",
                    "actions": [
                        {
                            "type": "create",
                            "description": "電解液パネルのご注文",
                            "resource": {
                                "resourceType": "ProcedureRequest",
                                "id": "8c6514e3-1d47-47b6-87b3-fc53ce8f6eb2",
                                "status": "draft",
                                "intent": "order",
                                "code": {
                                    "coding": [
                                        {
                                            "system": "http://snomed.info/sct",
                                            "code": "271236005",
                                            "display": "血清カリウム値"
                                        },
                                        {
                                            "system": "http://snomed.info/sct",
                                            "code": "312475002",
                                            "display": "血漿マグネシウムレベル"
                                        },
                                        {
                                            "system": "http://snomed.info/sct",
                                            "code": "390963002",
                                            "display": "血漿カルシウム濃度"
                                        }
                                    ],
                                    "text": "電解質パネル"
                                },
                                "subject": {
                                    "reference": "f001"
                                }
                            }
                        }
                    ]
                }
            ],
            "links": [
                {
                    "label": "ジゴキシン-シクロスポリン PDDI 知識成果物",
                    "url": "http://hl7.org/fhir/ig/PDDI-CDS/derived-from#digoxin-cyclosporine-knowledge-artifact"
                },
                {
                    "label": "(Lip et al. Postgrad Med J. 1993; 69(811):337)",
                    "url": "http://hl7.org/fhir/ig/PDDI-CDS/citation#lip1993"
                },
                {
                    "label": "(Digoxin-FDA [prescribing information] NDA 20405/S-004)",
                    "url": "http://hl7.org/fhir/ig/PDDI-CDS/citation#nda20405"
                }
            ]
        }
    ]
}
```


